Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiac Arrest
- Sponsor
- Jonathan Elmer
- Enrollment
- 4
- Locations
- 1
- Primary Endpoint
- Occult Seizures
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
Cardiac arrest is the most common cause of death in the United States and as many as 590,000 Americans suffering a cardiac arrest each year. Despite advances in care, as many as 50 to 89% of patients who are resuscitated after a cardiac arrest die in the hospital. Brain injury is the most common cause of death and disability after cardiac arrest. The investigators use advanced brain monitoring in patients who are at high risk of death after cardiac arrest, with the goal of preventing ongoing brain injury. The most common problem the investigators have observed is low oxygen levels in the brain, which is often very difficult to treat.
In this study, the investigators plan to use two additional brain monitors in the care of these high risk patients: a monitor for seizures and a monitor of the amount of blood flow in the brain. The investigators will use these to detect and treat potential causes of low brain oxygen levels. The main hypotheses are that electrical events in the brain such as seizures and "spreading depolarizations" will occur during times of low brain tissue oxygen level, and that treating these events and low blood flow will reduce the rate of low brain oxygen levels.
Investigators
Jonathan Elmer
Assistant Professor, Department of Emergency Medicine
University of Pittsburgh
Eligibility Criteria
Inclusion Criteria
- •High risk survivors of cardiac arrest
- •Decision by potential subject's clinical team to use our institutional standard invasive, multimodal neurologic monitoring for post-arrest care
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Occult Seizures
Time Frame: Participants will be followed for the duration of invasive monitoring, an expected average of 5 days
Seizures detected by intracortical EEG but not surface EEG
Spreading Depolarizations
Time Frame: Participants will be followed for the duration of invasive monitoring, an expected average of 5 days
Cerebral Hypoperfusion
Time Frame: Participants will be followed for the duration of invasive monitoring, an expected average of 5 days
Secondary Outcomes
- Monitor-associated Infection(Participants will be followed for the duration of the initial hospitalization, an expected average of 2 weeks)
- Clinically Significant Bleeding(Participants will be followed for the duration of the initial hospitalization, an expected average of 2 weeks)
- Device Malfunction(Participants will be followed for the duration of invasive monitoring, an expected average of 5 days)